StonvexLoading…
StonvexStonvexStonvexCore line items from KSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $15.53B | $16.22B | $17.48B | $18.10B |
Operating Income | $624.00M | $433.00M | $717.00M | $246.00M |
Net Income | $272.00M | $109.00M | $317.00M | $-19.00M |
EPS (Diluted) | $2.38 | $0.98 | $2.85 | $-0.15 |
Total Assets | $13.36B | $13.56B | $14.01B | $14.35B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $674.00M | $134.00M | $183.00M | $153.00M |
Free Cash Flow OCF − CapEx | $1.01B | $182.00M | $591.00M | $-544.00M |
Shares Outstanding | 114.00M | 112.00M | 111.00M | 120.00M |